Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Spectrum Pharmaceuticals patents

Patents where

Current Assignee

Name

Spectrum Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9295666 Bladder cancer treatment and methods	Patent 9295666 was granted and assigned to Spectrum Pharmaceuticals on March, 2016 by the United States Patent and Trademark Office.	Spectrum Pharmaceuticals	Spectrum Pharmaceuticals	United States Patent and Trademark Office	9295666	March 29, 2016
‌ US Patent 9511091 Rare earth metal compounds, methods of making, and methods of using the same	Patent 9511091 was granted and assigned to Spectrum Pharmaceuticals on December, 2016 by the United States Patent and Trademark Office.	Spectrum Pharmaceuticals	Spectrum Pharmaceuticals	United States Patent and Trademark Office	9511091	December 6, 2016
‌ US Patent 8715603 Rare earth metal compounds, methods of making, and methods of using the same	Patent 8715603 was granted and assigned to Spectrum Pharmaceuticals on May, 2014 by the United States Patent and Trademark Office.		Spectrum Pharmaceuticals	United States Patent and Trademark Office	8715603	May 6, 2014
‌ US Patent 8734818 Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives	Patent 8734818 was granted and assigned to Spectrum Pharmaceuticals on May, 2014 by the United States Patent and Trademark Office.	Spectrum Pharmaceuticals	Spectrum Pharmaceuticals	United States Patent and Trademark Office	8734818	May 27, 2014
‌ US Patent 8961917 Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use	Patent 8961917 was granted and assigned to Spectrum Pharmaceuticals on February, 2015 by the United States Patent and Trademark Office.		Spectrum Pharmaceuticals	United States Patent and Trademark Office	8961917	February 24, 2015
‌ US Patent 11267858 Methods of treatment using G-CSF protein complex	Patent 11267858 was granted and assigned to Spectrum Pharmaceuticals on March, 2022 by the United States Patent and Trademark Office.	Spectrum Pharmaceuticals	Spectrum Pharmaceuticals	United States Patent and Trademark Office	11267858	March 8, 2022
‌ US Patent 9308235 Treatment of primary and metastatic carcinoma	Patent 9308235 was granted and assigned to Spectrum Pharmaceuticals on April, 2016 by the United States Patent and Trademark Office.	Spectrum Pharmaceuticals	Spectrum Pharmaceuticals	United States Patent and Trademark Office	9308235	April 12, 2016
‌ US Patent 8648108 Medical compositions for intravesical treatment of bladder cancer	Patent 8648108 was granted and assigned to Spectrum Pharmaceuticals on February, 2014 by the United States Patent and Trademark Office.		Spectrum Pharmaceuticals	United States Patent and Trademark Office	8648108	February 11, 2014
‌ US Patent 8440620 Methods, compositions and articles of manufacture for contributing to the treatment of cancers	Patent 8440620 was granted and assigned to Spectrum Pharmaceuticals on May, 2013 by the United States Patent and Trademark Office.		Spectrum Pharmaceuticals	United States Patent and Trademark Office	8440620	May 14, 2013
‌ US Patent 9713616 Pharmaceutical compositions comprising L-leucovorin	Patent 9713616 was granted and assigned to Spectrum Pharmaceuticals on July, 2017 by the United States Patent and Trademark Office.	Spectrum Pharmaceuticals	Spectrum Pharmaceuticals	United States Patent and Trademark Office	9713616	July 25, 2017
‌ US Patent 8852543 Rare earth metal compounds, methods of making, and methods of using the same	Patent 8852543 was granted and assigned to Spectrum Pharmaceuticals on October, 2014 by the United States Patent and Trademark Office.	Spectrum Pharmaceuticals	Spectrum Pharmaceuticals	United States Patent and Trademark Office	8852543	October 7, 2014
‌ US Patent 9000031 Thioxanthone-based autophagy inhibitor therapies to treat cancer	Patent 9000031 was granted and assigned to Spectrum Pharmaceuticals on April, 2015 by the United States Patent and Trademark Office.		Spectrum Pharmaceuticals	United States Patent and Trademark Office	9000031	April 7, 2015
‌ US Patent 8273716 Use of LHRH antagonists for intermittent treatments	Patent 8273716 was granted and assigned to Spectrum Pharmaceuticals on September, 2012 by the United States Patent and Trademark Office.		Spectrum Pharmaceuticals	United States Patent and Trademark Office	8273716	September 25, 2012
‌ US Patent 8815953 Formulations of vitamin K analogs for topical use			Spectrum Pharmaceuticals	United States Patent and Trademark Office	8815953	August 26, 2014
‌ US Patent 7977369 Medical compositions for intravesical treatment of bladder cancer	Patent 7977369 was granted and assigned to Spectrum Pharmaceuticals on July, 2011 by the United States Patent and Trademark Office.		Spectrum Pharmaceuticals	United States Patent and Trademark Office	7977369	July 12, 2011
‌ US Patent 8063233 Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives	Patent 8063233 was granted and assigned to Spectrum Pharmaceuticals on November, 2011 by the United States Patent and Trademark Office.		Spectrum Pharmaceuticals	United States Patent and Trademark Office	8063233	November 22, 2011
‌ US Patent 10022421 Treatment of primary and metastatic carcinoma	Patent 10022421 was granted and assigned to Spectrum Pharmaceuticals on July, 2018 by the United States Patent and Trademark Office.	Spectrum Pharmaceuticals	Spectrum Pharmaceuticals	United States Patent and Trademark Office	10022421	July 17, 2018
‌ US Patent 8349802 Methods and compositions for contributing to the treatment of cancers	Patent 8349802 was granted and assigned to Spectrum Pharmaceuticals on January, 2013 by the United States Patent and Trademark Office.		Spectrum Pharmaceuticals	United States Patent and Trademark Office	8349802	January 8, 2013
‌ US Patent 8377456 Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives	Patent 8377456 was granted and assigned to Spectrum Pharmaceuticals on February, 2013 by the United States Patent and Trademark Office.		Spectrum Pharmaceuticals	United States Patent and Trademark Office	8377456	February 19, 2013
‌ US Patent 8563592 Bladder cancer treatment and methods	Patent 8563592 was granted and assigned to Spectrum Pharmaceuticals on October, 2013 by the United States Patent and Trademark Office.		Spectrum Pharmaceuticals	United States Patent and Trademark Office	8563592	October 22, 2013
‌ US Patent 8524762 Thioxanthone-based autophagy inhibitor therapies to treat cancer			Spectrum Pharmaceuticals	United States Patent and Trademark Office	8524762	September 3, 2013
‌ US Patent 6982269 Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives	Patent 6982269 was granted and assigned to Spectrum Pharmaceuticals on January, 2006 by the United States Patent and Trademark Office.		Spectrum Pharmaceuticals	United States Patent and Trademark Office	6982269	January 3, 2006
‌ US Patent 6894071 Medical compositions for intravesical treatment of bladder cancer	Patent 6894071 was granted and assigned to Spectrum Pharmaceuticals on May, 2005 by the United States Patent and Trademark Office.		Spectrum Pharmaceuticals	United States Patent and Trademark Office	6894071	May 17, 2005

23 results

0 selected

23 results

0 selected